HSD17B2
protein-codinghydroxysteroid 17-beta dehydrogenase 2, the group of Short chain dehydrogenase/reductase superfamily
Gene summary
Enables estradiol 17-beta-dehydrogenase [NAD(P)+] activity and testosterone dehydrogenase (NAD+) activity. Involved in androgen metabolic process; estrogen biosynthetic process; and response to retinoic acid. Located in endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~63.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HSD17B2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002153.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 4 | 5 | |||
| missense | 73 | 8 | 3 | 84 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 73 | 9 | 7 | 89 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002144.1 | 5 | MANE Select | |
| Ensembl | ENSP00000199936.4 | 5 | MANE Select | |
| Ensembl | ENSP00000455992.1 | 2 | Standard | |
| Ensembl | ENSP00000457943.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Steroid hormone biosynthesis - Homo sapiens (human)
- Ovarian steroidogenesis - Homo sapiens (human)
- Androgen Receptor Network in Prostate Cancer
- Vitamin D Receptor Pathway
- Steroid Biosynthesis
Biological Process
- in utero embryonic development
- placenta development
- estrogen biosynthetic process
- response to retinoic acid
- oxidation-reduction process
Molecular Function
- estradiol 17-beta-dehydrogenase activity
- 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity
- testosterone dehydrogenase (NAD+) activity
Cellular Component
- endoplasmic reticulum membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000199936
- Coding exons
- 5
- Length
- 63531
- Individuals with no LoFs
- 125541
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 207
- Defined
- 125748
- p
- 0.000823
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.57 | 279 | 214 | 1.30 | 0.0000113 | 2500 |
| Missense (PolyPhen) | 89 | 69.93 | 1.2727 | 815 | ||
| Synonymous | -2.89 | 126 | 90.9 | 1.39 | 0.00000534 | 772 |
| Loss of Function | -0.436 | 14 | 12.3 | 1.13 | 6.05e-7 | 148 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00043 | 0.00043 | rare |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.0027 | 0.0027 | notable |
| European (Non-Finnish) | 0.0011 | 0.0011 | notable |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0.0011 | 0.0011 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Capable of catalyzing the interconversion of testosterone and androstenedione, as well as estradiol and estrone. Also has 20-alpha-HSD activity. Uses NADH while EDH17B3 uses NADPH.;
Intolerance Scores
- LoFtool
- 0.326
- RVIS EVS
- 0.2
- RVIS percentile EVS
- 67.36
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.915
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |